{"title":"Endoscopic Transpapillary Gallbladder Stenting for Symptomatic Gallbladder Diseases","authors":"TH Lee, DH Park","doi":"10.1016/S2212-0971(13)70207-3","DOIUrl":null,"url":null,"abstract":"<div><p>Endoscopic transpapillary gallbladder drainage for symptomatic gallbladder disease is a safe and effective bridge therapy in patients at high risk for surgery or who have terminal liver disease awaiting transplantation. However, there are few reports on long-term results in terms of stent patency and clinical course. We investigated the long-term patency and clinical course after endoscopic transpapillary gallbladder stenting (ETGS) in patients who were unsuitable for cholecystectomy with symptomatic gallbladder disease. ETGS using a 7 F double-pigtail stent between the gallbladder and the duodenum was performed successfully in 79.3% in our institutions. Postprocedure complications were mild pancreatitis (8.7%) and cholestasis (8.7%), all of which resolved with conservative management. During the follow-up period (median 586 days, range 11–1403 days), median stent patency was 760 days, as determined by the Kaplan-Meier method. As a primary therapy, ETGS is technically feasible and provide long-term stent patency without the need for scheduled stent exchanges in patients who are unsuitable for cholecystectomy. This article is part of an expert video encyclopedia.</p></div>","PeriodicalId":101274,"journal":{"name":"Video Journal and Encyclopedia of GI Endoscopy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S2212-0971(13)70207-3","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Video Journal and Encyclopedia of GI Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212097113702073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Endoscopic transpapillary gallbladder drainage for symptomatic gallbladder disease is a safe and effective bridge therapy in patients at high risk for surgery or who have terminal liver disease awaiting transplantation. However, there are few reports on long-term results in terms of stent patency and clinical course. We investigated the long-term patency and clinical course after endoscopic transpapillary gallbladder stenting (ETGS) in patients who were unsuitable for cholecystectomy with symptomatic gallbladder disease. ETGS using a 7 F double-pigtail stent between the gallbladder and the duodenum was performed successfully in 79.3% in our institutions. Postprocedure complications were mild pancreatitis (8.7%) and cholestasis (8.7%), all of which resolved with conservative management. During the follow-up period (median 586 days, range 11–1403 days), median stent patency was 760 days, as determined by the Kaplan-Meier method. As a primary therapy, ETGS is technically feasible and provide long-term stent patency without the need for scheduled stent exchanges in patients who are unsuitable for cholecystectomy. This article is part of an expert video encyclopedia.